The Effectiveness and Mechanism of Character Strengths-based STEP Programme on Rehabilitation of Stroke Patients
Launched by PEKING UNIVERSITY · Feb 18, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program called the Character Strengths-based STEP Programme (CSSTEP) to see how it can help stroke patients during their rehabilitation. The goal is to improve not just their physical recovery but also their mental well-being, helping them feel more confident and less depressed after a stroke. Researchers believe that focusing on individual strengths—like what patients are good at or what they enjoy—can motivate them to engage more actively in their rehabilitation process.
To be eligible for this study, participants must be at least 18 years old and have been diagnosed with a stroke within the last 30 days. They should be able to understand and cooperate with the study, and their vital signs should be stable. However, those with serious cognitive impairments or other severe health issues may not qualify. Participants can expect to take part in various activities that aim to boost their mental and physical health while receiving support tailored to their personal strengths. This innovative approach is an exciting step in helping stroke patients recover better and faster.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ① Clinical diagnosis of stroke, CT or MRI diagnosis of cerebral infarction;
- • ② Within 30 days after clinical diagnosis of acute stroke;
- • ③ Age ≥18 years;
- • ④ Basic cognition, learning ability and willingness, all vital signs were stable, no other serious complications and no history of mental illness;
- • ⑤ Informed consent and cooperation.
- Exclusion Criteria:
- • ① Moderate or severe cognitive impairment (defined as mini-mental state examination score ≤20);
- • ② Unstable vital signs, accompanied by severe heart, liver, renal insufficiency, respiratory failure and malignant tumors, unable to intervene.
About Peking University
Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Patients applied
Trial Officials
Tingting YAN, PhD
Principal Investigator
Peking University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials